United States · FDA National Drug Code directory
Nicotine Polacrilex
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-089_b0db32b2-4ace-4fbe-a319-029ce7d54251
- Product NDC
- 45802-089
- Form
- LOZENGE
- Composition / generic term
- Nicotine Polacrilex
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160708
- Source listing expiry
- 20271231
Source-listed ingredients
- NICOTINE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 CONTAINER in 1 CARTON (45802-089-02) / 27 LOZENGE in 1 CONTAINER (45802-089-01) · 45802-089-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →